Jodi Hafemeister

[Jodi Hafemeister @Jodi_Hafe]

If you or someone you know is navigating #breastcancer, tomorrow's webinar is worth your time. Register: https://t.co/lLDbtSj2t6

Experts from @PinkRibbonGood and @NateraOncology will cover how testing can personalize your care and guide treatment decisions — straight from the people who know it best.

Understanding your options is one of the most empowering things a patient can do. Please share with anyone who may benefit.

[Natera @NateraGenetics]

Yesterday we announced financial results for the 1st quarter of 2026. We delivered strong performance across all areas of focus, capping an exciting period of growth for Natera. The quarter included a number of important milestones, anchored by data generation, innovation, and a powerful commitment to our mission. Most importantly, we continue to remain confident in our ability to continue transforming care for our patients.

https://t.co/zWsW0jSaHu

[Jodi Hafemeister @Jodi_Hafe]

Join @NateraOncology at #ASBrS2026 Wednesday April 29, 5:00pm.

Join @md_rosen Dr. Barry Rosen; Dr. @CarinneAnderson to explore how tumor-informed MRD testing can be integrated into modern #breastsurgery care.

RSVP: https://t.co/dYYzEEw8VV

#BreastOncology #ctDNA

[Natera @NateraGenetics]

The ability to detect phased variants – two or more single nucleotide variants (SNVs) co-occurring on the same DNA molecule – is redefining ultrasensitive limits of detection for minimal residual disease (MRD). Because the likelihood of these linked mutations arising by chance is extremely low, phased variants support enhanced error suppression and increase confidence in variant calls at very low allele frequencies.

Signatera™ Genome RUO now integrates PhasED-Seq™, a proprietary phased variant detection technology originally developed at Foresight Diagnostics (now part of Natera), delivering ultrasensitive MRD detection at scale to our pharmaceutical and research partners.

In this webinar, Max Diehn, MD, PhD, co-founder of Foresight Diagnostics, will provide an overview of PhasED-Seq™ technology, clinical data highlights and promising applications. An expert Q&A session will follow.

Register here: https://t.co/jswOli4l0n

[Jodi Hafemeister @Jodi_Hafe]

Join #Natera today at #EBCC15 for an Industry Forum exploring the role of ctDNA in breast cancer management.

We’ll be discussing clinical applications and what this means for real-world decision-making.

In the Exhibit Hall at 16:45. Register now! https://t.co/A7PujoUaed

[Natera @NateraGenetics]

Register today for our upcoming webinar with @FengtingYan and Jamie McKenzie, MD highlighting three of the twelve studies presented at the San Antonio Breast Cancer Symposium (SABCS).

Reserve your spot: https://t.co/qnqeQEGGMH

This virtual program will review and discuss findings from:
• PALLAS (Signatera™ Genome)1: Record-High Prognostic Performance in HR+/HER2- Early Breast Cancer

• Signatera™ Genome: Strong Prognostic Performance Beyond Imaging

• LEADER: MRD-Guided Insights in HR+ Early Breast Cancer

#Natera #ctDNA

[Jodi Hafemeister @Jodi_Hafe]

Heading to EBCC 2026?

Be part of the conversation on optimizing breast cancer management using individualized molecular monitoring for MRD-guided treatment at the industry forum.

👉 Secure your spot: https://t.co/SqqWWFefuK

[Rebecca Shatsky, MD @Dr_RShatsky]

The great ⁦@JAMouabbi⁩ gesticulating wildly as he speaks about ctDNA monitoring in breast cancer. Love this guy and his passion. #BTGBreast2025 #MGHLifeSciences

[Jodi Hafemeister @Jodi_Hafe]

Attending #ASBrS24? Join our dinner symposium with roundtable discussions. Hear how Dr. Anjeanette Brown, Dr. Kandace McGuire, and Dr. Rhianna Menen use novel localization and lymphatic mapping techniques to elevate patient care. Save Your Seat!: https://t.co/JczWxbZXDO

[Jodi Hafemeister @Jodi_Hafe]

This is a great seminar with hands-on practice from an experienced physician, @AlisaSumkin. Check it out!

[MTMI @MTMIRadiates]

Explore 3D and 2D stereotactic and ultrasound-guided breast biopsy procedures and gain insights into best practices and cutting-edge techniques. #breastbiopsy #ultrasound

Register for one or both days here: https://t.co/Q70oUA57lA

[Jodi Hafemeister @Jodi_Hafe]

@AmyOvitt 4 words…. The word “I”

[Jodi Hafemeister @Jodi_Hafe]

@mdAlvaradoMD @endomag @Magtrace @MagseedSurgery An amazing advance in women's health to avoid surgery in the axilla for almost 80% of DCIS patients. Now THAT'S meaningful!

[Jodi Hafemeister @Jodi_Hafe]

While at SBI, mix up your day from lectures & advance your skills at a hands-on learning lab! An experienced physician will walk you through techniques that help conquer challenging biopsies in both the breast & axilla. Sign up: https://t.co/l5SXEyFQ6T #SBIACR2022 #BREASTIMAGING

[Dr. Susan K. Boolbol @SBoolbol]

It takes a team to care for and treat #breastcancer. That is what every patient deserves. #BreastCancerAwarenessMonth @NuvanceHealth @Vassar_Brothers @NorwalkHospital @DanburyHospital @ndutchesshosp

[Nuvance Health @NuvanceHealth]

Dr. @SBoolbol, chief of breast surgical oncology and breast program, shares the different roles that make up a #breastcancer treatment care team and why a team approach is important.

For more on breast cancer care and treatment at Nuvance Health, visit https://t.co/lMcig6Wa26

[Jodi Hafemeister @Jodi_Hafe]

It’s an honor to support an organization that directly benefits patients!!

[Jodi Hafemeister @Jodi_Hafe]

Great opportunity for hands-on instruction!

[Hud Shaker @hudshaker]

Signed up already! This will be a very interesting and useful webinar for trainees and breast surgeons alike.